Resources

This six-minute video provides a brief tutorial on how to use PATH’s Vaccine Cost Calculators for middle-income countries. These Excel-based tools are available in English, French, and Spanish and offer an easy way to compare the costs of certain vaccination programs with each vaccine product available in the global market. The video is in English, with French and Spanish subtitled versions also available.For middle-income countries, we currently offer calculators for pneumococcal conjugate vaccines and rotavirus vaccines. These tools allow country-level decision-makers and implementers, as well as technical assistance partners, to input local data and then compare estimated vaccination program costs for different vaccine products and presentations, exploring multiple vaccine options at once. The calculators enable users to compare the estimated cold chain volume and financial costs of different vaccination programs annually and for a total period of five years. Users also can add domestically produced vaccine options that are not available in the global market, as well as compare costs for up to three different scenarios of multi-vaccine use for countries that plan to use more than one product at the same time.

The primer provides the data, messages, and resources to help understand the planning, policies, and technologies involved in oxygen delivery scale-up. The materials are useful to anyone who wants to learn about scaling up access to oxygen and integrating oxygen delivery across national and subnational policies, programs, and health budgets.This primer was originally published in 2017, with an updated version in 2025.

Oxygen therapy is an essential part of ending preventable deaths among children and adults globally. However, reliable access to oxygen, paired with pulse oximetry, remains inadequate across many health facilities in low- and middle-income countries for many reasons. Limited data, perceptions about costs, poor understanding of the impact on health outcomes, and the complexity of integration and maintenance across the health system all contribute to decreased access.Scaling up access to oxygen is one of the most effective and critical actions decision-makers can take to improve health outcomes and save lives. The Oxygen Delivery Toolkit: Resources to plan and scale medical oxygen provides materials to help decision-makers, implementers, and advocates plan, manage, and communicate the value of scaling up oxygen delivery systems and access to oxygen and pulse oximetry.This guide provides a summary of the toolkit resources, as well as intended users. The toolkit is available at www.path.org/oxygen-delivery-toolkit.Updated in February 2025 to reflect new or revised resources in the toolkit.

This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various vaccine approaches being worked on around the world.This snapshot pairs with the RSV and mAb Trial Tracker, which provides publicly available information on clinical trials of RSV candidate vaccines and mAbs intended for prevention.

This spreadsheet provides publicly available information on clinical trials of respiratory syncytial virus (RSV) candidate vaccines and monoclonal antibodies intended for prevention.Sources of information for these trials are clinicaltrials.gov; who.int/clinical-trials-registry-platform; clinicaltrialsregister.eu; and anzctr.org.au, which includes clinical trial registries from 17 countries.Some information is also obtained through contact with investigators, sponsors, and funders of vaccine trials. This spreadsheet pairs with the RSV Vaccine and mAb Snapshot, which provides a summary of the RSV vaccine and mAb candidates in development worldwide.